Creative Planning Ab Cellera Biologics Inc. Transaction History
Creative Planning
- $116 Billion
- Q2 2025
A detailed history of Creative Planning transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Creative Planning holds 41,003 shares of ABCL stock, worth $227,566. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,003
Previous 38,347
6.93%
Holding current value
$227,566
Previous $85,000
64.71%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ABCL
# of Institutions
150Shares Held
115MCall Options Held
538KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY27.5MShares$153 Million0.96% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$74.2 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$57.8 Million0.04% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL8.47MShares$47 Million0.01% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$25.2 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.58B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...